| 1 |
33383282 | Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling. | 2021 Apr |
6 |
| 2 |
34017439 | Dexmedetomidine attenuates acute kidney injury in children undergoing congenital heart surgery with cardiopulmonary bypass by inhibiting the TLR3/NF-κB signaling pathway. | 2021 |
4 |
| 3 |
31774572 | Dexmedetomidine prevents desflurane-induced motor neuron death through NF-KappaB pathway. | 2020 Jan |
1 |
| 4 |
32335082 | Dexmedetomidine protects intestinal ischemia-reperfusion injury via inhibiting p38 MAPK cascades. | 2020 Aug |
1 |
| 5 |
32377171 | Inhibition of carrageenan-induced dental inflammatory responses owing to decreased TRPV1 activity by Dexmedetomidine. | 2020 |
2 |
| 6 |
32377532 | Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling. | 2020 |
3 |
| 7 |
32525823 | Dexmedetomidine alleviates smoke-induced bronchial and alveolar epithelial cell injury. | 2020 May |
1 |
| 8 |
32851338 | Effects of dexmedetomidine on the expression of inflammatory factors in children with congenital heart disease undergoing intraoperative cardiopulmonary bypass: a randomized controlled trial. | 2020 Mar |
1 |
| 9 |
33029092 | Anti-inflammatory effects of dexmedetomidine on human amnion-derived WISH cells. | 2020 |
4 |
| 10 |
31243816 | Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway. | 2019 Oct |
5 |
| 11 |
29100037 | Dexmedetomidine promotes liver regeneration in mice after 70% partial hepatectomy by suppressing NLRP3 inflammasome not TLR4/NFκB. | 2018 Jan |
5 |
| 12 |
29241031 | The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. | 2018 Feb |
3 |
| 13 |
29393492 | Dexmedetomidine impairs P‑glycoprotein‑mediated efflux function in L02 cells via the adenosine 5'‑monophosphate‑activated protein kinase/nuclear factor‑κB pathway. | 2018 Apr |
1 |
| 14 |
28829488 | The effect of dexmedetomidine on expressions of inflammatory factors in patients with radical resection of gastric cancer. | 2017 Aug |
1 |
| 15 |
22939552 | Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro. | 2013 May |
1 |
| 16 |
23609293 | Dexmedetomidine suppresses proinflammatory mediator production in human whole blood in vitro. | 2013 May |
2 |